Clinical Trial Details

EORTC-30831

Back to Clinical Trials Database

Phase III trial of mitomycin C in primary and recurrent Ta-T1 papillary carcinoma of the bladder randomized between immediate vs delayed administration and maintenance vs no maintenance treatment

Study documentation

Trial Status All trial activities ended
Dates Date Step1 close: 01-Feb-1986
Data management at EORTC
Design Phase 3
Randomized open label
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/
NCT number